TScan Therapeutics
TCRX
#8994
Rank
NZ$0.16 B
Marketcap
$2.68
Share price
0.00%
Change (1 day)
-79.26%
Change (1 year)

EPS for TScan Therapeutics (TCRX)

EPS in 2023 (TTM): -$4.72

According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.84. In 2022 the company made an earnings per share (EPS) of -$4.61 a decrease over its 2021 EPS that were of -$3.65.

EPS history for TScan Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.722.39%
2022-$4.6126.25%
2021-$3.6599.58%
2020-$1.83